Biotech

All Articles

2 cancer cells biotechs merge, developing worldwide footprint

.OncoC4 is actually taking AcroImmune-- and its in-house medical manufacturing capabilities-- under ...

Amgen documents first period 3 win for $400M dermatitis drug

.Amgen has actually shared (PDF) the first period 3 data on its $400 million dermatitis medication, ...

Biogen, UCB document phase 3 lupus gain after neglecting earlier trial

.Biogen and also UCB's gamble on improving in to stage 3 astride a failed research study tries to ha...

Aptadir hopes brand-new RNA inhibitors may reverse complicated cancers cells

.Italian biotech Aptadir Rehabs has actually launched with the guarantee that its own pipeline of pr...

Wave surfs DMD excellence to regulatory authorities' doors, sending out stock up

.Surge Lifestyle Sciences has fulfilled its own objective in a Duchenne muscular dystrophy (DMD) res...

Sanofi plucks brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma layer, using up the b...

Achilles trickles cell therapy system, braces for unemployments after missing 'business viability' goals

.Achilles Rehabs has actually destroyed its approach. The British biotech is quiting working on its ...

Aligos proclaims stage 2 MASH gain, slashing liver excess fat up to 46%

.Aligos Therapeutics is actually proclaiming a midstage win in metabolic-dysfunction affiliated stea...

Basilea credit ratings $268M BARDA funding for antifungals, antibiotics

.Basilea Pharmaceutica's work creating brand-new antifungals has actually obtained a substantial imp...

Capricor offers Europe civil rights to late-stage DMD therapy for $35M

.Having actually scooped up the united state civil rights to Capricor Therapeutics' late-stage Duche...